Clinical Data & Research
The future of early detection
With BacterioScan’s 30-180 minute turnaround time, results are available 1-2 days faster than current methods, for quicker detection of infection and better patient care.
Clinical Proof
Results from 3,000 sample clinical study across three US hospital laboratories
Built on our patented laser macribial growth technology, our platform rapidly detects infection and antibiotic resistance, helping clinicians act sooner, use antibiotics more effectively, and combat resistance.
The science enables actionable answers before antibiotics are prescribed.
When evaluating specimens with uropathogens present at 50,000CFU/mL or greater, BacterioScan delivers: 97.7% Sensitivity and 99.2% Negative Predictive Value.
High sensitivity/NPV provides a definite negative in 180 minutes, allowing better stewardship and patient care.
Research Partners & Clinical Users
Our research partners are key opinion leaders driving development and adoption; >80% of our partners have hosted or published our clinical research
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!